Association between the Metabolic Syndrome and High Tumor Grade and Stage of Primary Urothelial Cell Carcinoma of the Bladder |
Ozbek, Emin
(Okmeydani Training and Research Hospital Department of Urology)
Otunctemur, Alper (Okmeydani Training and Research Hospital Department of Urology) Dursun, Murat (Okmeydani Training and Research Hospital Department of Urology) Koklu, Ismail (Okmeydani Training and Research Hospital Department of Urology) Sahin, Suleyman (Okmeydani Training and Research Hospital Department of Urology) Besiroglu, Huseyin (Okmeydani Training and Research Hospital Department of Urology) Erkoc, Mustafa (Okmeydani Training and Research Hospital Department of Urology) Danis, Eyyup (Okmeydani Training and Research Hospital Department of Urology) Bozkurt, Muammer (Okmeydani Training and Research Hospital Department of Urology) |
1 | Reeves GK, Pirie K, Beral V, et al (2007). Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ, 335, 1134. DOI ScienceOn |
2 | Rosengren A, Himmelmann A, Wilhelmsen L, Branehog I, Wedel H (1998). Hypertension and long-term cancer incidence and mortality among Swedish men. J Hypertens, 16, 933-40. DOI |
3 | Samanic C, Gridley G, Chow WH, et al (2004). Obesity and cancer risk among white and black United States veterans. Cancer Causes Control, 15, 35-43. DOI |
4 | Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr (2006). Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control, 17, 901-9. DOI ScienceOn |
5 | Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA: A Cancer J Clin, 62, 10-29. DOI ScienceOn |
6 | Stocks T, Rapp K, Bjorge T, Manjer J, Ulmer H (2009). Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med, 6, 1000201. DOI |
7 | Stumpe KO (2002). Hypertension and the risk of cancer: is there new evidence? J Hypertens, 20, 565-7. DOI |
8 | Yang XQ, Xu C, Sun Y, Han RF (2013). Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis. Asian Pac J Cancer Prev, 14, 2583-9. 과학기술학회마을 DOI ScienceOn |
9 | Zhao H, Grossman HB, Spitz MR, et al (2003). Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol, 169, 714-7. DOI ScienceOn |
10 | Larsson SC, Andersson SO, Johansson JE, Wolk A (2008). Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur J Cancer, 44, 2655-60. DOI ScienceOn |
11 | Jee SH, Yun JE, Park EJ, et al (2008). Body mass index and cancer risk in Korean men and women. Int J Cancer, 123, 1892-6. DOI ScienceOn |
12 | Jee SH, Ohrr H, Sull JW, et al (2005). Fasting serum glucose level and cancer risk in Korean men and women. JAMA, 293, 194-202. DOI ScienceOn |
13 | Koebnick C, Michaud D, Moore SC, et al (2008). Body mass index, physical activity, and bladder cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev, 17, 1214-21. DOI ScienceOn |
14 | Lee MY, Lin KD, Hsiao PJ, Shin SJ (2012). The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients. Metabolism, 61, 242-9. DOI |
15 | Li N, Yang L, Zhang Y, et al (2011). Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis, 204, 217-23. DOI ScienceOn |
16 | Funfstuck R, Nicolle LE, Hanefeld M, Naber KG (2012). Urinary tract infection in patients with diabetes mellitus. Clin Nephrol, 77, 40-8. DOI |
17 | Liu X, Ji J, Sundquist K, Sundquist J, Hemminki K (2012). The impact of type 2 diabetes mellitus on cancer-specific survival: a follow-up study in Sweden. Cancer, 118, 1353-61. DOI |
18 | Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, et al (2007). Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol, 25, 285-95. DOI ScienceOn |
19 | Qin Q, Xu X, Wang X, et al (2013). Obesity and risk of bladder cancer: a meta-analysis of cohort studies. Asian Pac J Cancer Prev, 14, 3117-21. 과학기술학회마을 DOI ScienceOn |
20 | Haggstrom C, Stocks T, Rapp K, et al (2011). Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can). International journal of cancer. Journal international du cancer, 128, 1890-8. DOI ScienceOn |
21 | Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011). Association between smoking and risk of bladder cancer among men and women. JAMA, 306, 737-45. DOI ScienceOn |
22 | Gorbachinsky I, Akpinar H, Assimos DG (2010). Metabolic syndrome and urologic diseases. Rev Urol, 12, 157-80. |
23 | Hiatt RA, Fireman BH (1986). Serum cholesterol and the incidence of cancer in a large cohort. J Chronic Dis, 39, 861-70. DOI |
24 | Hole DJ, Hawthorne VM, Isles CG, et al (1993). Incidence of and mortality from cancer in hypertensive patients. BMJ, 306, 609-11 DOI |
25 | Batty GD, Shipley MJ, Jarrett RJ, et al (2005). Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study. Int J Obes, 29, 1267-74. DOI |
26 | Holick CN, Giovannucci EL, Stampfer MJ, Michaud DS (2007). Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women. Int J Cancer, 120, 140-6. DOI |
27 | Hu J, La Vecchia C, de Groh M, et al (2012). Dietary cholesterol intake and cancer. Ann Oncol, 23, 491-500. DOI ScienceOn |
28 | Jankovic S, Radosavljevic V (2007). Risk factors for bladder cancer. Tumori, 93, 4-12. |
29 | Borena W, Strohmaier S, Lukanova A, et al (2011). Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. Int J Cancer, 43, 1-25. |
30 | Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med, 348, 1625-38. DOI ScienceOn |
31 | Chen HS, Su LT, Lin SZ, et al (2012). Increased risk of urinary tract calculi among patients with diabetes mellitus - a population-based cohort study. Urology, 79, 86-92. DOI ScienceOn |
32 | Chow WH, Lindblad P, Gridley G, et al (1997). Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst, 89, 1453-7. DOI ScienceOn |
33 | Cowey S, Hardy RW (2006). The metabolic syndrome: A highrisk state for cancer? Am J Pathol, 169, 1505-22. DOI ScienceOn |
34 | Currie CJ, Poole CD, Jenkins-Jones S, et al (2012). Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival. Diabetes Care, 35, 299-304. DOI |
35 | Grove JS, Nomura A, Severson RK, Stemmermann GN (1991). The association of blood Pressure with cancer incidence in a prospective Study. Am J Epidemiol, 134, 942-7. |
36 | Dunn SE1, Kari FW, French J, et al (1997). Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res, 57, 4667-72. |
37 | Eckel RH (2007). Treating dyslipidemia of the metabolic syndrome: where's the evidence? Nat Clin Pract Endocrinol Metab, 3, 437. DOI ScienceOn |